de Fine Olivarius et al. BMC Public Health 2011, 11:80 http://www.biomedcentral.com/1471-2458/11/80 36. Attebo K, Mitchell P, Smith W: Visual acuity and the causes of visual loss in Australia - The blue mountains eye study. Ophthalmology 1996, 103:357-364. 37. Smith GD, Phillips AN: Inflation in epidemiology: ‘’The proof and measurement of association between two things’’ revisited. BMJ 1996, 312:1659-1661. 38. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL, Knatterud GL: Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early treatment diabetic retinopathy study report #18. Invest Ophthalmol Vis Sci 1998, 39:233-252. 39. Keech AC, Mitchell P, Summanen PA, O’Day J, Davis TM, Moffitt MS, Taskinen MR, Simes RJ, Tse D, Williamson E, et al: Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007, 370:1687-1697. 40. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR: UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001, 44:156-163. 41. Klein R, Klein BE, Moss SE: Visual impairment in diabetes. Ophthalmology 1984, 91:1-9. 42. Idil A, Caliskan D, Ocaktan E: The prevalence of blindness and low vision in older onset diabetes mellitus and associated factors: a community- based study. Eur J Ophthalmol 2004, 14:298-305. 43. Olafsdottir E, Andersson DK, Stefansson E: Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease. Acta Ophthalmol Scand 2007, 85:40-45. 44. Trautner C, Haastert B, Giani G, Berger M: Incidence of blindness in southern Germany between 1990 and 1998. Diabetologia 2001, 44:147-150. 45. Voutilainen-Kaunisto RM, Terasvirta ME, Uasitupa MIJ, Niskanen LK: Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects 10-year follow-up from the diagnosis. J Diab Comp 2001, 15:24-33. 46. Agardh E, Agardh CD, Hansson-Lundblad C: The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med 1993, 10:555-559. 47. Klein R, Klein BEK, Lee KE, Cruickshanks KJ, Gangnon RE: Changes in visual acuity in a population over a 15-year period: The Beaver Dam Eye Study. Am J Ophthalmol 2006, 142:539-549. 48. Knudtson MD, Klein BEK, Klein R: Age-related eye disease, visual impairment, and survival - The Beaver Dam Eye Study. Arch Ophthalmol 2006, 124:243-249. 49. Hartnett ME, Key IJ, Loyacano NM, Horswell RL, DeSalvo KB: Perceived barriers to diabetic eye care - Qualitative study of patients and physicians. Arch Ophthalmol 2005, 123:387-391. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2458/11/80/prepub doi:10.1186/1471-2458-11-80 Cite this article as: de Fine Olivarius et al.: Prevalence and progression of visual impairment in patients newly diagnosed with clinical type 2 diabetes: a 6-year follow up study. BMC Public Health 2011 11:80. Page 13 of 13 Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit